Postdoc in Human Pluripotent Stem Cell-based Cell Therapy in Type 1 Diabetes DanStem, University of Copenhagen

Posted 6/7/2018

We are looking for a postdoctoral candidate with a strong cell biological and cell signaling background in directed differentiation of human pluripotent stem cell biology. The candidate is expected to work on the engineering of human pluripotent stem cell-derived islet of Langerhans-like aggregates with functional properties close to human islets. The functionality and therapeutic potential of the aggregates will be tested in vitro and in vivo in mice.

The goal of this project is to engineer therapeutically active islet-like aggregates for future cell therapy phase 1 trials in Type 1 Diabetes (T1D). 

The candidate is expected to use state-of-the-art genetics, molecular and cell biological, and tissue engineering experimental strategies. The candidate will work together with a dedicated team of scientists and technicians who together will tackle bottle-necks towards implementing the phase 1 clinical trials in T1D. 

Deadline for applications is July 15, 2018

Last Updated 06/07/2018